Valuation (53%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 31.41 | N/A |
| PEG Ratio (TTM) | 1.75 | N/A |
| P/S Ratio (TTM) | 6.72 | N/A |
| P/B Ratio (TTM) | 0.84 | N/A |
| P/FCF Ratio (TTM) | N/A | N/A |
| Price to 5YR AVG Earnings Ratio | 46.47 | N/A |
| Price to 5YR AVG FCF Ratio | 26.85 | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.67% | N/A |
| ROE (TTM) | 2.71% | N/A |
| Net Profit Margin (TTM) | 17.15% | N/A |
| ROIC 5YR AVG | 5.20% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 61.91% | 22.19% | 16.41% |
| Revenue | 0.23% | 8.13% | 5.39% |
| Net Income | 61.26% | 24.35% | 11.12% |
| Cash Flow | N/A | 46.37% | 23.10% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | 0.04 | N/A |
| Interest Coverage (TTM) | -0.02 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.55 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | -4.89% | N/A |